ALFA FinderBSE filing, NSE: AAREYDRUGS. Summary written from the filing by ALFA Finder's alert engine.
Aarey Drugs & Pharmaceuticals Ltd: key numbers
- Share price
- ₹107.72
- Market cap
- ₹305.4 Cr
- Revenue (annual)
- ₹472.3 Cr
- Net profit (annual)
- ₹3.97 Cr
- P/E (TTM)
- 73.2×Sector 43.0×
- Promoter holding
- 41.45%+3.74% QoQ
- FII holding
- 4.28%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aarey Drugs & Pharmaceuticals Ltd
All →Aarey Drugs & Pharmaceuticals Other Announcement
Aarey Drugs & Pharmaceuticals Ltd filed its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulations.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs approved allotment of 1,150,000 equity shares from warrant conversion at ₹47.85 each, receiving ₹5.50 Crore. Issued capital rises to 31,874,303 shares.
- Value
- ₹5.50 Cr
Aarey Drugs & Pharmaceuticals Capital Structure Change
Promoter and promoter group of Aarey Drugs & Pharmaceuticals Ltd acquired 23.70 lakh shares following the conversion of warrants. The acquisition increased their stake by 4.81%.
- Promoter stake change
- +4.81%
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs allotted equity shares to promoters following the conversion of 23,40,000 warrants. This capital structure change increases the promoters' equity stake in the company.
- Value
- ₹11.20 Cr
Aarey Drugs & Pharmaceuticals Annual General Meeting
Aarey Drugs & Pharmaceuticals Ltd. held its 36th Annual General Meeting on September 30, 2026, to conduct business including financial statement adoption and director re-appointment.
Aarey Drugs & Pharmaceuticals Capital Structure Change
Aarey Drugs & Pharmaceuticals Ltd approved the allotment of 11,50,000 equity shares following the conversion of warrants. The allotment aggregate value is Rs. 7.34 Crore.
- Value
- ₹7.34 Cr
Other board meeting date announcements
All →Sahara Maritime Board Meeting Date
Sahara Maritime Ltd intimated BSE of a board meeting on November 13, 2026 to approve unaudited half-year results ended September 30, 2026. The trading window stays closed until 48 hours after results declaration.
Euro Panel Products Board Meeting Date
Euro Panel Products will hold a board meeting on November 14, 2026 for unaudited September 2026 quarter results. The trading window stays closed until November 16, 2026.
Tejnaksh Healthcare Board Meeting Date
Tejnaksh Healthcare will hold a board meeting on 12 November 2026 to consider unaudited Q2 standalone and consolidated results. The filing also notes the trading window closure.
Shree Marutinandan Industries Board Meeting Date
Shree Marutinandan Industries will hold a board meeting on 14 November 2026 to approve unaudited standalone and consolidated results for the half year ended 30 September 2026. Trading window is closed from 1 October 2026.
Magson Retail & Distribution Board Meeting Date
Magson Retail rescheduled its board meeting from 7 November to 9 November 2026 to consider half-year results. The trading window stays closed until 11 November 2026.
Promax Power Board Meeting Date
Promax Power scheduled a board meeting for 14 November 2026 to consider half-year unaudited results. The agenda is proposed only, with no figures disclosed.